Valuation Collegium Pharmaceutical, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 14:32:58 2026-08-06 EDT			5-day change	1st Jan Change
29.46 ^USD	-17.57%		-18.15%	-36.39%

11:51am	Collegium Pharmaceutical, Inc. Revises Earnings Guidance for the Year 2026	CI
09:24am	Collegium Pharmaceutical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	650	778.9	1,004	924	1,464	1,159	-	-
Change	-	19.82%	28.87%	-7.95%	58.4%	-20.8%	-	-
Enterprise Value (EV)	650	778.9	1,004	924	1,464	1,159	1,159	1,159
Change	-	19.82%	28.87%	-7.95%	58.4%	-20.8%	0%	0%
P/E	10x	-31.4x	23.9x	15.4x	26.8x	-	-	-
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	-0x	0.3x	-3.83x	-	-	-
Capitalization / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	1.33x	1.35x	1.39x
EV / Revenue	0x	0x	0x	0x	0x	1.33x	1.35x	1.39x
EV / EBITDA	0x	0x	0x	0x	0x	2.4x	2.65x	3.2x
EV / EBIT	0x	0x	0x	0x	0x	2.45x	2.67x	2.97x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.86	-0.74	1.29	1.86	1.73	-	-	-
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	276.9	463.9	566.8	631.4	780.6	869.9	860.2	833.9
EBITDA ¹	118.3	266	367	401.2	460.5	482.8	437.7	362.7
EBIT ¹	17.63	33.32	167	169.9	179.6	473.6	434.2	389.7
Net income	71.52	-25	48.16	69.19	62.87	-	-	-
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	18.68	23.20	30.78	28.65	46.30	35.74	35.74	35.74
Nbr of stocks (in thousands)	34,797	33,572	32,611	32,250	31,611	32,434	-	-
Announcement Date	2/24/22	2/23/23	2/22/24	2/27/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLLEGIUM PHARMACEUTICAL, INC.	-	-	-	-	1.16B
ELI LILLY AND COMPANY	34.15x	12.3x	24.81x	0.59%	1,043B
JOHNSON & JOHNSON	28.65x	6.33x	17.69x	2.09%	621B
ABBVIE INC.	32.22x	7.27x	14.86x	2.81%	435B
ROCHE HOLDING AG	20.32x	4.82x	11.94x	2.74%	361B
NOVARTIS AG	21.88x	5.66x	14.13x	2.83%	293B
ASTRAZENECA PLC	20.89x	4.29x	12.19x	2.05%	251B
AMGEN INC.	25.57x	6.75x	12.03x	2.47%	220B
NOVO NORDISK A/S	12.99x	4.77x	10.28x	3.82%	201B
GILEAD SCIENCES, INC.	-41.73x	5.88x	33.15x	2.46%	164B
Average	17.22x	6.45x	16.79x	2.43%	359.03B
Weighted average by Cap.	24.48x	7.75x	18.10x	2%